In the comparability exercise carried out with biosimilar insulin glargine, similarity between the pharmacokinetic and pharmacodynamic parameters with the reference insulin has been demonstrated. It has also shown the same in the security profile.
Industry news
In the comparability exercise carried out with biosimilar insulin glargine, similarity between the pharmacokinetic and pharmacodynamic parameters with the reference insulin has been demonstrated. It has also shown the same in the security profile.
recently published
Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.